The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...

Women are disproportionately affected by HIV, making up nearly half of new infections globally and in India. Stigma, gender ...

The safety profile of the regimen was also found to be comparable to Biktarvy. ・Merck now intends to present findings from ...

Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...

Merck on Wednesday said the Phase 3 study of the once-daily, two-drug single-tablet regimen met the success criterion for its primary efficacy hypothesis, showing non-inferiority to the three-drug ...

From medical neglect to suicide, the lack of information on jail deaths can allow the same deadly problems to lead to more ...

Between 2021 and 2023, COVID-19 dropped from the world’s leading cause of death to the 20th, while life expectancy surpassed ...

In an article published in The Lancet HIV, authors including Distinguished Professor Denis Nash and Professor Constantin Yiannoutsos aim to provide the most comprehensive estimates of pediatric ...

Our researchers have worked at the forefront of HIV care, research, education, and policy since the earliest stages of the epidemic. We conduct basic, translational, and implementation research here ...

Owners of the Cambridge-based pharmaceutical distributor Safe Chain Solutions were convicted in a Florida federal court on Wednesday for distributing counterfeit and black-market HIV drugs. A jury ...

According to court records from when they were indicted last year, the Boyds and partner Adam Brosius sent more than $90 million in payments to HIV drug suppliers for adulterated, misbranded and ...

The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain. While symptoms can now be better managed with lifelong treatment, there is ...